Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Insys founder, former executives face opioid kickback scheme trial
Source: Reuters
U.S. LEGAL NEWS JANUARY 28, 2019 / 6:07 AM / UPDATED 2 HOURS AGO
Insys founder, former executives face opioid kickback scheme trial
Nate Raymond
3 MIN READ
BOSTON (Reuters) - The one-time billionaire founder of Insys Therapeutics Inc and four other former executives and managers of the opioid drugmaker will face trial over charges they conspired to pay doctors bribes to prescribe patients an addictive fentanyl spray to boost sales.
Lawyers are set to deliver opening statements Monday in federal court in Boston in the case of former Insys chairman John Kapoor, the highest-level executive of a painkiller manufacturer to be tried amid a deadly U.S. opioid abuse epidemic.
Prosecutors say Kapoor directed a kickback scheme that helped fuel the epidemic in order to boost the company’s sales of Subsys, an under-the-tongue fentanyl spray approved only for use in managing severe pain in cancer patients.
Fentanyl is an opioid 100 times stronger than morphine.
Net revenues for Subsys grew from $8.6 million in 2012 to $329 million in 2015, according to Insys.
-snip-
Insys founder, former executives face opioid kickback scheme trial
Nate Raymond
3 MIN READ
BOSTON (Reuters) - The one-time billionaire founder of Insys Therapeutics Inc and four other former executives and managers of the opioid drugmaker will face trial over charges they conspired to pay doctors bribes to prescribe patients an addictive fentanyl spray to boost sales.
Lawyers are set to deliver opening statements Monday in federal court in Boston in the case of former Insys chairman John Kapoor, the highest-level executive of a painkiller manufacturer to be tried amid a deadly U.S. opioid abuse epidemic.
Prosecutors say Kapoor directed a kickback scheme that helped fuel the epidemic in order to boost the company’s sales of Subsys, an under-the-tongue fentanyl spray approved only for use in managing severe pain in cancer patients.
Fentanyl is an opioid 100 times stronger than morphine.
Net revenues for Subsys grew from $8.6 million in 2012 to $329 million in 2015, according to Insys.
-snip-
Read more: https://www.reuters.com/article/us-insys-opioids/insys-founder-former-executives-face-opioid-kickback-scheme-trial-idUSKCN1PM11F
